Birdwatch Note
2024-11-19 18:12:21 UTC - NOT_MISLEADING
The US was the first, and—for awhile—only country to allow direct-to-consumer pharma advertising. https://pmc.ncbi.nlm.nih.gov/articles/PMC2001072/ France does not allow direct-to-consumer pharma advertising for prescription drugs and is a bad example. https://cms.law/en/int/expert-guides/cms-expert-guide-to-advertising-of-medicines-and-medical-devices/france
Written by 721F7CFA27E19F4E16B6CF0907834DC07E5ABB925AA2E3E01745CEAAE672FC0E
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1858731724295074205
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1858936364076876132
- noteId - 1858936364076876132
- participantId -
- noteAuthorParticipantId - 721F7CFA27E19F4E16B6CF0907834DC07E5ABB925AA2E3E01745CEAAE672FC0E
- createdAtMillis - 1732039941221
- tweetId - 1858731724295074205
- classification - NOT_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 1
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- The US was the first, and—for awhile—only country to allow direct-to-consumer pharma advertising. https://pmc.ncbi.nlm.nih.gov/articles/PMC2001072/ France does not allow direct-to-consumer pharma advertising for prescription drugs and is a bad example. https://cms.law/en/int/expert-guides/cms-expert-guide-to-advertising-of-medicines-and-medical-devices/france
Note Ratings
| rated at | rated by | |
| 2024-11-20 17:06:12 -0600 | Rating Details | |
| 2024-11-20 15:36:05 -0600 | Rating Details | |
| 2024-11-20 11:43:57 -0600 | Rating Details | |
| 2024-11-20 07:17:19 -0600 | Rating Details | |
| 2024-11-20 07:07:14 -0600 | Rating Details | |
| 2024-11-20 05:16:11 -0600 | Rating Details | |
| 2024-11-20 04:28:52 -0600 | Rating Details | |
| 2024-11-20 02:17:30 -0600 | Rating Details | |
| 2024-11-20 00:32:52 -0600 | Rating Details | |
| 2024-11-19 22:52:29 -0600 | Rating Details | |
| 2024-11-19 22:45:54 -0600 | Rating Details | |
| 2024-11-19 22:38:30 -0600 | Rating Details | |
| 2024-11-19 21:10:41 -0600 | Rating Details | |
| 2024-11-19 21:07:53 -0600 | Rating Details | |
| 2024-11-19 20:55:15 -0600 | Rating Details | |
| 2024-11-19 20:43:09 -0600 | Rating Details | |
| 2024-11-19 20:32:14 -0600 | Rating Details | |
| 2024-11-19 20:30:51 -0600 | Rating Details | |
| 2024-11-19 20:11:50 -0600 | Rating Details | |
| 2024-11-19 19:40:43 -0600 | Rating Details | |
| 2024-11-19 19:36:37 -0600 | Rating Details | |
| 2024-11-19 19:11:14 -0600 | Rating Details | |
| 2024-11-19 18:53:48 -0600 | Rating Details | |
| 2024-11-19 18:44:20 -0600 | Rating Details | |
| 2024-11-19 18:35:04 -0600 | Rating Details | |
| 2024-11-19 18:10:26 -0600 | Rating Details | |
| 2024-11-19 17:27:07 -0600 | Rating Details | |
| 2024-11-19 17:11:23 -0600 | Rating Details | |
| 2024-11-19 16:50:24 -0600 | Rating Details | |
| 2024-11-19 16:43:10 -0600 | Rating Details | |
| 2024-11-19 16:00:19 -0600 | Rating Details | |
| 2024-11-19 15:20:04 -0600 | Rating Details | |
| 2024-11-19 15:01:44 -0600 | Rating Details | |
| 2024-11-19 14:24:03 -0600 | Rating Details | |
| 2024-11-19 13:56:46 -0600 | Rating Details | |
| 2024-11-19 13:19:57 -0600 | Rating Details | |
| 2024-11-19 12:16:36 -0600 | Rating Details | |
| 2024-11-21 12:11:27 -0600 | Rating Details | |
| 2024-11-21 06:24:33 -0600 | Rating Details | |
| 2024-11-20 22:43:49 -0600 | Rating Details | |
| 2024-11-20 21:37:48 -0600 | Rating Details | |
| 2024-11-20 19:08:21 -0600 | Rating Details | |
| 2024-11-23 07:37:35 -0600 | Rating Details | |
| 2024-11-21 19:04:57 -0600 | Rating Details | |
| 2024-11-21 06:55:15 -0600 | Rating Details | |
| 2024-11-20 10:10:02 -0600 | Rating Details | |
| 2024-11-20 00:29:37 -0600 | Rating Details | |
| 2024-11-19 22:46:15 -0600 | Rating Details | |
| 2024-11-19 21:49:50 -0600 | Rating Details | |
| 2024-11-19 19:35:24 -0600 | Rating Details | |
| 2024-11-19 18:37:48 -0600 | Rating Details | |
| 2024-11-19 18:12:41 -0600 | Rating Details | |
| 2024-11-19 17:26:23 -0600 | Rating Details | |
| 2024-11-19 15:40:45 -0600 | Rating Details | |
| 2024-11-19 15:26:25 -0600 | Rating Details | |
| 2024-11-19 14:31:27 -0600 | Rating Details | |
| 2024-11-19 14:08:43 -0600 | Rating Details | |
| 2024-11-19 14:00:38 -0600 | Rating Details | |
| 2024-11-23 06:41:45 -0600 | Rating Details | |
| 2024-11-21 00:32:09 -0600 | Rating Details | |
| 2024-11-20 16:32:12 -0600 | Rating Details | |
| 2024-11-20 15:14:04 -0600 | Rating Details | |
| 2024-11-20 14:41:07 -0600 | Rating Details | |
| 2024-11-20 12:55:31 -0600 | Rating Details | |
| 2024-11-20 08:42:12 -0600 | Rating Details | |
| 2024-11-20 06:59:09 -0600 | Rating Details | |
| 2024-11-20 03:52:49 -0600 | Rating Details | |
| 2024-11-20 00:45:09 -0600 | Rating Details | |
| 2024-11-19 21:27:11 -0600 | Rating Details | |
| 2024-11-19 19:15:59 -0600 | Rating Details | |
| 2024-11-19 17:10:59 -0600 | Rating Details | |
| 2024-11-19 17:04:41 -0600 | Rating Details | |
| 2024-11-19 14:15:15 -0600 | Rating Details | |
| 2024-11-19 14:04:47 -0600 | Rating Details |